We currently have no Breaking News on this stock.
ISCO vs. ETF Alternatives
International Stem Cell Corporation is a California-based biotechnology company developing novel stem cell based therapies and biomedical products. ISCO's core technology, parthenogenesis, creates pluripotent human stem cells from unfertilized eggs. These stem cells avoid ethical issues... More
Other News & PR